Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Applied Biosystems™ TaqPath™ COVID-19 Diagnostic PCR Kit

K-Number: K233453 · 2024-07-10

Decision Date2024-07-10
Product CodeQQX
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

Applied Biosystems™ TaqPath™ COVID-19 Diagnostic PCR Kit is a medical device manufactured by Life Technologies Corporation. It received FDA 510(k) clearance on 2024-07-10 under approval number K233453. The device is classified under product code QQX. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Applied Biosystems™ TaqPath™ COVID-19 Diagnostic PCR Kit?

Applied Biosystems™ TaqPath™ COVID-19 Diagnostic PCR Kit is a medical device that received FDA 510(k) clearance on 2024-07-10. It is manufactured by Life Technologies Corporation. The 510(k) number is K233453.

When was Applied Biosystems™ TaqPath™ COVID-19 Diagnostic PCR Kit approved by the FDA?

Applied Biosystems™ TaqPath™ COVID-19 Diagnostic PCR Kit received FDA 510(k) clearance on 2024-07-10, under approval number K233453.

What company makes Applied Biosystems™ TaqPath™ COVID-19 Diagnostic PCR Kit?

Applied Biosystems™ TaqPath™ COVID-19 Diagnostic PCR Kit is manufactured by Life Technologies Corporation.

What is the FDA product code for Applied Biosystems™ TaqPath™ COVID-19 Diagnostic PCR Kit?

The FDA product code for Applied Biosystems™ TaqPath™ COVID-19 Diagnostic PCR Kit is QQX.

Related Clinical Trials

Related PubMed Literature

Other Devices by Life Technologies Corporation

Related Devices (Code: QQX)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.